Stocks of the Hour: Lake Resources, Talon Energy, Actinogen Medical
A snapshot of the stocks on the move, featuring Lake Resources (ASX:LKE), Talon Energy (ASX:TPD) and Actinogen Medical (ASX:ACW).
Read More
Actinogen Medical Limited
Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing an innovative treatment for cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. ‘Cognition’ relates to how a person understands and acts in the world around them. Cognitive functions include memory, reasoning, awareness and decision-making, and to a large extent, influences our personality.
Actinogen Medical’s lead drug candidate, Xanamem, has been specifically designed to block the production of cortisol – the stress hormone – in the brain. Chronically elevated cortisol is associated with cognitive decline in Alzheimer’s disease, anxiety in Fragile X syndrome, and cognitive impairment in schizophrenia and diabetes.
Xanamem offers a promising new approach to treat cognitive impairment associated with these neurodegenerative, psychiatric, and metabolic diseases.
In the Company’s recent XanaHES Phase I trial, Xanamem exhibited a statistically significant improvement in cognition among healthy elderly volunteers treated with 20mg Xanamem daily, building on the encouraging data from the earlier XanADu study. The Company plans to initiate a range of Phase II studies evaluating Xanamem in the treatment of cognitive impairment associated with Alzheimer’s disease, Fragile X syndrome, schizophrenia, and diabetes.
Spotlight Videos
Stocks of the Hour: Lake Resources, Talon Energy, Actinogen Medical
A snapshot of the stocks on the move, featuring Lake Resources (ASX:LKE), Talon Energy (ASX:TPD) and Actinogen Medical (ASX:ACW).
WATCH VIDEOAll Actinogen Medical Limited Content
News
Actinogen Medical (ASX:ACW) – Webinar Presentation
Dr. Steven Gourlay - Managing Director & CEO - Actinogen Medical is a biotechnology company developing an innovative treatment for cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol.
Read More
A pipeline of disease applications within one pill
Steven Gourlay - CEO & MD - Actinogen Medical is a biotechnology company developing an innovative treatment for cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol.
Read More
Picking The One Cent Wonders That Could Become Dollar Dazzlers
When a stock is trading at a fraction of a cent, it’s usually a message for investors to abandon all hope and sell for the tax losses while they can. But ‘penny dreadful’ shares can sometimes rise from the ashes.
Read More
